Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2025-12-25 @ 5:00 AM
NCT ID:
NCT01685918
Eligibility Criteria:
Inclusion Criteria:
1. Retrospective study
* Patients who satisfy the 1987 ACR classification criteria for RA
* Patients with RA who have received or are receiving biologic agents including infliximab, etanercept, adalimumab, rituximab.
2. Prospective study
* Patients who satisfy the 1987 ACR classification criteria for RA
* Patients with RA who have received or are receiving biologic agents including infliximab, etanercept, adalimumab, rituximab, abatacept.
Exclusion Criteria:
1. Patients younger than eighteen
2. Patients enrolled in clinical trials
3. For the prospective study: Sex and Reproductive Status
1. WOCBP who are unwilling or unable to use an acceptable method to avoid pregnancy for the entire study period and for up to 10 weeks after the last dose of study drug.
2. Women who are pregnant or breastfeeding.
3. Women with a positive pregnancy test on enrollment
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01685918
Study Brief:
Protocol Section:
NCT01685918